“…The present results are consistent with those reported by Tomotake et al and Aki et al, who assessed subjective QOL and depressive symptoms with SQLS and the Calgary Depression Scale for Schizophrenia, respectively. 10,11 In the current study, drug-induced extrapyramidal symptoms, cognitive factor, and positive factor were correlated with symptoms/side-effects scale scores of SQLS, and stepwise regression showed that druginduced extrapyramidal symptoms predicted the symptoms/side-effects scale score. The present result suggests that the extrapyramidal symptom is a factor negatively influencing subjective QOL.…”